Tenon Medical, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Experienced medical devices industry executive joins tenon's board of directors los gatos, ca / accesswire / march 28, 2024 / tenon medical, inc. (nasdaq:tnon) ("tenon" or the "company"), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced that kristine jacques has been appointed as an independent member of the company's board of directors on march 25, 2024, effective immediately. following this appointment, tenon medical's board of directors consists of seven members, including four independent directors.

Preliminary si joint fusion results based on independent radiologist review indicate robust fusion at 12-months post-procedure initial patient results demonstrate marked improvements in pain scores and disability, along with high patient satisfaction ratings los gatos, ca / accesswire / march 26, 2024 / tenon medical, inc. (nasdaq:tnon) ("tenon" or the "company"), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced significant progress in the post-market study utilizing the company's catamaran® si joint fusion system. the study is a prospective, multi-center, single-arm post market study evaluating the clinical outcomes of patients with sacroiliac joint disruptions or degenerative sacroiliitis treated with the catamaran si joint fusion system.

Fourth quarter 2023 revenue increased 192% year-over-year full year 2023 revenue increased 324% year-over-year surgical procedures increased 179% year-over-year in the fourth quarter and 312% for the full year 2023 achieved three consecutive quarters of positive gross profit margin in 2023 catamaran® si joint fusion system included in a series of immersive physician webinar training programs attended by sixty healthcare providers in q4 los gatos, ca / accesswire / march 12, 2024 / tenon medical, inc. (nasdaq:tnon) ("tenon medical" or the "company"), a company transforming care for patients suffering with certain sacroiliac joint (si joint) disorders, today reported financial results for the fourth quarter and full year ended december 31, 2023...

Los gatos, ca / accesswire / february 27, 2024 / tenon medical, inc. (nasdaq:tnon) ("tenon" or the "company"), a company transforming care for patients suffering with certain sacroiliac joint (si joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended december 31, 2023 after market close on tuesday, march 12, 2024. the company will also hold a conference call the same day at 4:30 p.m.

Received notice of allowance from the uspto on february 15, 2024 los gatos, ca / accesswire / february 22, 2024 / tenon medical, inc. ("tenon" or the "company") (nasdaq:tnon), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced that on february 15, 2024, the united states patent and trademark office ("uspto") issued a notice of allowance for u.s. patent application serial number 18/107,536 for tenon's catamaran® si joint implant for stabilizing a dysfunctional sacroiliac (si) joint. a u.s. patent based on u.s. patent application serial number 18/107,536 should thus issue within the next ninety (90) days.

Tenon Medical, Inc (TNON) Q4 2023 Earnings Call Transcript

LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024. The Company will also hold a conference call the same day at 4:30 p.m.

LOS GATOS, CA / ACCESSWIRE / November 2, 2023 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the third quarter 2023 ended September 30, 2023 after market close on Tuesday, November 14, 2023. The Company will also hold a conference call the same day at 4:30 p.m.

LOS GATOS, CA / ACCESSWIRE / April 25, 2023 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac disorders, today announced plans to release financial results for the first quarter 2023 ended March 31, 2023 after market close on Tuesday, May 9, 2023. The Company will also hold a conference call the same day at 4:30 p.m.

Tenon Medical (NASDAQ: TNON ) stock is taking off on Wednesday morning despite a lack of news from the medical device company. Instead, it looks like heavy trading is behind the rally of TNON stock today.

LOS GATOS, CA / ACCESSWIRE / November 2, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac disorders, today announced management's participation in the following upcoming conferences: Q4 Investor Summit, November 14-15, 2022. Steven Foster, Chief Executive Officer, and Steven Van Dick, Chief Financial Officer, will present at 9:30 a.m.

LOS GATOS, CA / ACCESSWIRE / September 14, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced that management will present during Benzinga's All Access investor event taking place Friday, September 16, 2022. Steve Foster, Chief Executive Officer of Tenon Medical, is scheduled to host a presentation and Q&A session during the event as follows.

At least one group is bullish about the outlook for the medtech industry: venture capitalists.

Can these penny stocks make gains next month? The post Top Penny Stocks to Buy Now?